Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling

Cell

Volumn 166, Issue 1, 2016, Pages 47-62

  Gao, Hua ^a,b   Chakraborty, Goutam ^b   Zhang, Zhanguo ^b,f   Akalay, Intissar ^b   Gadiya, Mayur ^b,c   Gao, Yaquan ^a   Sinha, Surajit ^b   Hu, Jian ^a   Jiang, Cizhong ^a   Akram, Muzaffar ^b   Brogi, Edi ^b   Leitinger, Birgit ^d   Giancotti, Filippo G ^b,e  

^a TONGJI UNIVERSITY   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Weill Graduate School of Medical Sciences of Cornell University   (United States)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN RECEPTOR; COLLAGEN TYPE 1; DISCOIDIN DOMAIN RECEPTOR 1; JANUS KINASE 2; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; SYNTENIN; TETRASPANIN; TETRASPANIN TM4SF1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; DDR1 PROTEIN, HUMAN; MEMBRANE ANTIGEN; TM4SF1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER STEM CELL; CELL SURFACE; DNA LIBRARY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC SCREENING; METASTASIS; METASTASIS FREE SURVIVAL; MOUSE; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET ORGAN; TUMOR GROWTH; UPREGULATION; ANIMAL; BREAST TUMOR; CHEMISTRY; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, SURFACE; BREAST NEOPLASMS; CELL LINE, TUMOR; DISCOIDIN DOMAIN RECEPTOR 1; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 84976870320     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.06.009     Document Type: Article

References (43)

1. Aguirre-Ghiso, J.A., Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7 (2007), 834–846.
2. Al Saleh, S., Al Mulla, F., Luqmani, Y.A., Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS ONE, 6, 2011, e20610.
3. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25 (2007), 1035–1044.
4. Borrell-Pagès, M., Fernández-Larrea, J., Borroto, A., Rojo, F., Baselga, J., Arribas, J., The carboxy-terminal cysteine of the tetraspanin L6 antigen is required for its interaction with SITAC, a novel PDZ protein. Mol. Biol. Cell 11 (2000), 4217–4225.
5. Bragado, P., Estrada, Y., Parikh, F., Krause, S., Capobianco, C., Farina, H.G., Schewe, D.M., Aguirre-Ghiso, J.A., TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. Nat. Cell Biol. 15 (2013), 1351–1361.
6. Brooks, A.J., Dai, W., O'Mara, M.L., Abankwa, D., Chhabra, Y., Pelekanos, R.A., Gardon, O., Tunny, K.A., Blucher, K.M., Morton, C.J., et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344, 2014, 1249783.
7. Canning, P., Tan, L., Chu, K., Lee, S.W., Gray, N.S., Bullock, A.N., Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors. J. Mol. Biol. 426 (2014), 2457–2470.
8. Carafoli, F., Mayer, M.C., Shiraishi, K., Pecheva, M.A., Chan, L.Y., Nan, R., Leitinger, B., Hohenester, E., Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling. Structure 20 (2012), 688–697.
9. Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V.B., Wong, E., Orlov, Y.L., Zhang, W., Jiang, J., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 (2008), 1106–1117.
10. Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., Wicha, M.S., In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17 (2003), 1253–1270.
11. Erler, J.T., Bennewith, K.L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.T., Chi, J.T., Jeffrey, S.S., Giaccia, A.J., Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440 (2006), 1222–1226.
12. Gao, D., Chen, Y., Organoid development in cancer genome discovery. Curr. Opin. Genet. Dev. 30 (2015), 42–48.
13. Gao, H., Chakraborty, G., Lee-Lim, A.P., Mo, Q., Decker, M., Vonica, A., Shen, R., Brogi, E., Brivanlou, A.H., Giancotti, F.G., The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 150 (2012), 764–779.
14. Gao, H., Chakraborty, G., Lee-Lim, A.P., Mavrakis, K.J., Wendel, H.G., Giancotti, F.G., Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation. Proc. Natl. Acad. Sci. USA 111 (2014), 16532–16537.
15. Ghajar, C.M., Metastasis prevention by targeting the dormant niche. Nat. Rev. Cancer 15 (2015), 238–247.
16. Ghajar, C.M., Peinado, H., Mori, H., Matei, I.R., Evason, K.J., Brazier, H., Almeida, D., Koller, A., Hajjar, K.A., Stainier, D.Y., et al. The perivascular niche regulates breast tumour dormancy. Nat. Cell Biol. 15 (2013), 807–817.
17. Giancotti, F.G., Mechanisms governing metastatic dormancy and reactivation. Cell 155 (2013), 750–764.
18. Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W.J., Inghirami, G., Giancotti, F.G., Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126 (2006), 489–502.
19. Hellstrom, I., Beaumier, P.L., Hellstrom, K.E., Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas. Proc. Natl. Acad. Sci. USA 83 (1986), 7059–7063.
20. Kobayashi, A., Okuda, H., Xing, F., Pandey, P.R., Watabe, M., Hirota, S., Pai, S.K., Liu, W., Fukuda, K., Chambers, C., et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med. 208 (2011), 2641–2655.
21. Leitinger, B., Transmembrane collagen receptors. Annu. Rev. Cell Dev. Biol. 27 (2011), 265–290.
22. Levental, K.R., Yu, H., Kass, L., Lakins, J.N., Egeblad, M., Erler, J.T., Fong, S.F., Csiszar, K., Giaccia, A., Weninger, W., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139 (2009), 891–906.
23. Marcotte, R., Brown, K.R., Suarez, F., Sayad, A., Karamboulas, K., Krzyzanowski, P.M., Sircoulomb, F., Medrano, M., Fedyshyn, Y., Koh, J.L., et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov. 2 (2012), 172–189.
24. Marken, J.S., Schieven, G.L., Hellström, I., Hellström, K.E., Aruffo, A., Cloning and expression of the tumor-associated antigen L6. Proc. Natl. Acad. Sci. USA 89 (1992), 3503–3507.
25. Marken, J.S., Bajorath, J., Edwards, C.P., Farr, A.G., Schieven, G.L., Hellström, I., Hellström, K.E., Aruffo, A., Membrane topology of the L6 antigen and identification of the protein epitope recognized by the L6 monoclonal antibody. J. Biol. Chem. 269 (1994), 7397–7401.
26. Mihai, C., Chotani, M., Elton, T.S., Agarwal, G., Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. J. Mol. Biol. 385 (2009), 432–445.
27. Noordeen, N.A., Carafoli, F., Hohenester, E., Horton, M.A., Leitinger, B., A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. J. Biol. Chem. 281 (2006), 22744–22751.
28. Paszek, M.J., Zahir, N., Johnson, K.R., Lakins, J.N., Rozenberg, G.I., Gefen, A., Reinhart-King, C.A., Margulies, S.S., Dembo, M., Boettiger, D., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8 (2005), 241–254.
29. Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131 (2007), 1190–1203.
30. Samuel, M.S., Lopez, J.I., McGhee, E.J., Croft, D.R., Strachan, D., Timpson, P., Munro, J., Schröder, E., Zhou, J., Brunton, V.G., et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 19 (2011), 776–791.
31. Sarkar, D., Boukerche, H., Su, Z.Z., Fisher, P.B., mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res. 68 (2008), 3087–3093.
32. Shan, Y., Gnanasambandan, K., Ungureanu, D., Kim, E.T., Hammarén, H., Yamashita, K., Silvennoinen, O., Shaw, D.E., Hubbard, S.R., Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase. Nat. Struct. Mol. Biol. 21 (2014), 579–584.
33. Tam, W.L., Lu, H., Buikhuisen, J., Soh, B.S., Lim, E., Reinhardt, F., Wu, Z.J., Krall, J.A., Bierie, B., Guo, W., et al. Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell 24 (2013), 347–364.
34. Toms, A.V., Deshpande, A., McNally, R., Jeong, Y., Rogers, J.M., Kim, C.U., Gruner, S.M., Ficarro, S.B., Marto, J.A., Sattler, M., et al. Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases. Nat. Struct. Mol. Biol. 20 (2013), 1221–1223.
35. Valencia, K., Ormazábal, C., Zandueta, C., Luis-Ravelo, D., Antón, I., Pajares, M.J., Agorreta, J., Montuenga, L.M., Martínez-Canarias, S., Leitinger, B., Lecanda, F., Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Clin. Cancer Res. 18 (2012), 969–980.
36. Vogel, W., Brakebusch, C., Fässler, R., Alves, F., Ruggiero, F., Pawson, T., Discoidin domain receptor 1 is activated independently of beta(1) integrin. J. Biol. Chem. 275 (2000), 5779–5784.
37. Wang, C.Z., Su, H.W., Hsu, Y.C., Shen, M.R., Tang, M.J., A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Mol. Biol. Cell 17 (2006), 2839–2852.
38. Wright, M.D., Ni, J., Rudy, G.B., The L6 membrane proteins–a new four-transmembrane superfamily. Protein Sci. 9 (2000), 1594–1600.
39. Wu-Zhang, A.X., Newton, A.C., Protein kinase C pharmacology: refining the toolbox. Biochem. J. 452 (2013), 195–209.
40. Xu, L., Li, Q., Xu, D., Wang, Q., An, Y., Du, Q., Zhang, J., Zhu, Y., Miao, Y., hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int. J. Oncol. 44 (2014), 459–466.
41. Young, R.A., Control of the embryonic stem cell state. Cell 144 (2011), 940–954.
42. Yu, H., Lee, H., Herrmann, A., Buettner, R., Jove, R., Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14 (2014), 736–746.
43. Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D.J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene 34 (2014), 3107–3119.